DRKS00024551Not yet recruitingNot Applicable
Monitoring the immune response of anti-SARS-CoV2 vaccinated individuals and COVID-19-positive patients – a prospective monocentric non-interventional observational study - Immu-COVID-19-SKD
Städtisches Klinikum Dessau. Medizinische Hochschule Brandenburg Theodor Fontane0 sites700 target enrollmentStarted: March 8, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 700
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Employees of the Dessau Medical Center, COVID-19 patients of the Dessau Medical Center, hemato-oncological patients of the Dessau Medical Center
Exclusion Criteria
- •Persons, who do not confirm their participation at the study
Investigators
Similar Trials
Completed
Unknown
Monitoring of immune responses following COVID-19 infection or vaccination in Bobo-Dioulasso, Burkina FasoCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN41192701Institut National de Santé Publique du Burkina Faso201
Active, not recruiting
Phase 1
Tracking the immune response to SARS-CoV-2 modRNA vaccines in an open-label multicenter study in participants with relapsing multiple sclerosis treated with ofatumumab s.c. (KYRIOS)EUCTR2021-000307-20-DEovartis Pharma Vertriebs GmbH40
Completed
Not Applicable
Investigation of the immune status against SARS-CoV-2 of medical professionals in Doctor's Practices in Thuringia (COVID-19 research project)SPECIFIC METHODS OF INVESTIGATION FOR SARSCOV2COVID19 VIRUS NOT CONFIRMED COVID19 O.N.A.U99.0U07.2COVID-19, virus not identifiedDRKS00021815Kassenärztliche Vereinigung Thüringen5,773
Active, not recruiting
Phase 1
SARS-Cov-2 vaccine responsiveness in middle-aged and older personsSARS-CoV-19, frailtyEUCTR2021-001976-40-NLational Institute for Public Health and the Environment1,700
Recruiting
Phase 4
Monitoring immunogenicity of SARS-Cov-2 vaccination in Dutch middle-aged and older individuals (participating in the Doetinchem Cohort Study)NL-OMON54058Ministerie van Volksgezondheid, Welzijn en Sport (VWS)1,700
